Skip to content
Home/Companies/Pharma/Acer Therapeutics
Acer Therapeutics

Acer Therapeutics

Pharma·United States·Exited 2023·Held 8yr
Entry
2015
Hold
8yr
Exit
2023

Who owns Acer Therapeutics?

Acer Therapeutics was owned by TVM Capital Life Science through TVM Life Science Ventures (2004 vintage) from 2015 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-11

TVM Capital Life Science
Investor
TVM Capital Life Science
TVM Life Science Ventures · 2004 · VC

Key facts

HQUnited States
SectorPharma
StatusAcquired
Websitewww.acerand.com
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from TVM Life Science Ventures

Other portfolio companies in the same fund.

CSA Medical, Inc.
Active
MedTechUnited States· 2024
Jacobian GmbH
Jacobian GmbH
Active
HealthTechGermany· 2024
Myosotis GmbH
Active
HealthTechGermany· 2024
Vektor Medical, Inc.
Active
MedTechUnited States· 2024
Zevra Therapeutics
Zevra Therapeutics
Active
PharmaUnited States· 2023
Egg Medical
Egg Medical
Active
MedTechUnited States· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Laboratoires Delbert
Active
SocadifFrance
AMW
AMW
Active
SHS Gesellschaft für BeteiligungsmanagementGermany· 2026
Basic Pharma
Active
SHS Gesellschaft für BeteiligungsmanagementNetherlands· 2026
Cinclus Pharma
Cinclus Pharma
Active
Claret Capital PartnersSweden· 2026
InfoRLife
Active
BC PartnersSwitzerland· 2026
IRAB
IRAB
Active
ARCHIMEDSpain· 2026
Track Acer Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Acer Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue